Immunology of infectious diseases; anti-schistosome immunity development in children; praziquantel mass drug administration in school children to control schistosomiasis in western Kenya; effect of infection with schistosomiasis on vaccine responses in adults and children in western Kenya; investigation into possible development of praziquantel resistance in schistosome isolates from the field, and elucidation of possible gene polymorphisms underlying praziquantel resistance. Hepatitis C/HIV co-infections and metabolic consequences in injection drug users in the coastal region of Kenya.
Collaborations: Kenya Medical Research Institute’s Center for Global Health Research (KEMRI-CGHR) in Kisumu, University of Georgia’s Center for Tropical and Emerging Global Diseases (UGA-CTEGD), Centers for Disease Control and Prevention (CDC)
Riner D. K., Ndombi E. M., Carter J. M., Omondi A., Kittur N., Kavere E., Korir H. K., Flaherty B., Karanja D. and Colley D. G. (2016). Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid. PLoS Neglected Tropical Diseases.
Eric M. Ndombi, Budambula Valentine, Mark W. Kilongosi, Francis O. Musumba, Joseph Karanja, Jesca O. Wesongah, Samwel A. Bonuke, Aabid A Ahmed, Raphael Lihana, and Tom Were 2015 Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users. European Journal of Endocrinology
Last Updated on Friday, 31 March 2017 11:37